A never-before-seen, highly plastic cell state may explain how cancer gains resistance to drugs. A few extremely malleable tumor cells are able to craft their epigenetic makeup to evade chemotherapy and produce new, resistant clones. Targeting this specific state may prolong treatment effectiveness.